October
21, 2024
– Bangalore, India: Pharmed Limited, one of India’s leading pharmaceutical
companies, has announced the launch of the India
Bone Health Initiative (IBHI) on World Osteoporosis Day, October 20, 2024.
The IBHI
is designed as a pioneering program to improve the overall health and
well-being of the Indian population. This strategic move aims to address the
growing concern of osteoporosis and bone health issues across India. It
leverages Pharmed’s extensive expertise in healthcare to make a significant
impact on public health, focusing on raising awareness about osteoporosis and
its impact on quality of life, providing patient education about bone health,
offering accessible Bone Mineral Density (BMD) testing through annual camps,
promoting early detection and prevention strategies for osteoporosis, and
collaborating with healthcare professionals to enhance bone health knowledge
and treatment capabilities.
Suneet
Aurora, Chairman & Managing Director of Pharmed Limited, emphasized the
company’s vision, stating, “At Pharmed, we envision a future where every
Indian citizen is aware of and empowered to maintain their bone health. The
India Bone Health Initiative manifests our long-standing commitment to this
vision. By integrating awareness, education, and accessible diagnostic
services, we aim to create a comprehensive ecosystem that addresses bone health
at every stage of life. This initiative is not just about ma osteoporosis; it is
about fostering a culture of preventive care and enabling Indians to lead
active, healthy lives well into their golden years.”
The
launch of IBHI builds upon Pharmed’s impressive track record in bone health
initiatives. Over the past two decades, the company has made an indelible
impact on millions of lives across India through its pioneering social welfare
programs. Pharmed’s flagship initiative, offering free BMD screening camps in
collaboration with Orthopaedicians across India, has reached millions of
patients helping them manage bone health using guidance and tools. These camps
provide crucial screenings and disseminate vital information on osteoporosis
prevention and management. Conducted nationwide in collaboration with esteemed
medical professionals, this initiative has garnered widespread acclaim from the
healthcare community for its commitment to public health awareness and early
detection.
Through
IBHI, Pharmed aims to foster an environment where patients are more informed
about bone health and can engage in meaningful discussions with their
healthcare providers. The initiative works alongside doctors to extend their
practice and raise awareness among patients, supporting a comprehensive
approach to bone health. By facilitating access to essential diagnostic
services and fostering partnerships within the medical fraternity, Pharmed has
set new standards for corporate social responsibility in the pharmaceutical
industry, contributing significantly to the overall well-being of communities
throughout India.
Kashmiri
Lal Kapoor, Director - Operations at Pharmed Limited, highlighted the
timely nature of the initiative, saying, “In today’s fast-paced world, where
sedentary lifestyles and poor nutrition habits are increasingly common,
initiatives like the IBHI are more crucial than ever. The rising incidence of
osteoporosis, particularly among our younger population, is a wake-up call.
This initiative is not just timely; it is imperative. By bringing bone health
to the forefront of public health discussions, we are addressing a silent
epidemic that affects millions. The IBHI is our response to the urgent need for
comprehensive, accessible bone health care in India, ensuring that we are not
just treating diseases but actively working to prevent them.”
This
holistic approach to bone health across all age groups underscores its
unwavering dedication to improving healthcare. Pharmed invites healthcare
professionals to join this mission to build a healthier India. Together, the
India Bone Health Initiative can make a lasting impact on the bone health of
our nation, improving lives and reducing the burden of osteoporosis on
individuals and families.
For more
information about the India Bone Health Initiative, please visit www.indiabonehealth.com.
Pharmed’s
Contact Information:
Jigar
Ganatra
Head
– Digital Marketing and Corporate Communications
Email:
jigar.ganatra@pharmed.in
Phone:
080 69278000 | Connect
on LinkedIn